Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
about
The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRsFluorescent approaches for understanding interactions of ligands with G protein coupled receptorsImpact of salt stress, cell death, and autophagy on peroxisomes: quantitative and morphological analyses using small fluorescent probe N-BODIPYReaction of amines with 8-methylthioBODIPY: dramatic optical and laser response to amine substitution.Fluorescent ligands for adenosine receptors.Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy.Biophysical Detection of Diversity and Bias in GPCR Function.Far-red and near infrared BODIPY dyes: synthesis and applications for fluorescent pH probes and bio-imaging.Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human β1-adrenoceptor expressed in HEK-293 cells.Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors.High-Affinity Functional Fluorescent Ligands for Human β-Adrenoceptors.Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.Time-resolved fluorescence ligand binding for G protein-coupled receptors.Micro-pharmacokinetics: Quantifying local drug concentration at live cell membranes.Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET
P2860
Q26991781-78E93BDB-9634-4ABC-A408-502AFBD68F15Q27004213-915B786A-D4CF-417E-A78B-E19F3E0BABFBQ34047918-6FD22113-33C3-4C8A-962C-71DBF02EB700Q34954824-C7753D64-E5F8-4814-B81C-C373122DE945Q36570374-4B1447CE-1B30-4E4D-BD1F-211FCABE5E10Q37446861-19246489-7AE4-4A5F-A61B-F1A3C646562FQ38181178-213AA118-3342-42C4-BD04-5DE8AFEF88D9Q38196401-35E1F2F6-3910-41C7-AB86-0D059450D846Q38208184-19162503-2187-4F8B-8D11-33643BD15A05Q39428983-96745489-400E-46BB-B67E-3487CB716F68Q40753310-B91981D5-73E2-43AE-AF10-2AB9003B6FC2Q42125718-7635653D-04A7-43CA-BE53-6C92AD6194A3Q42950461-5C003CC3-E627-41D3-BD0A-188FA9357127Q44793375-B541604F-E009-40BB-83F2-82A528496206Q46520207-87E59DDE-5618-40F3-83BD-5E22CF7E38DEQ50330984-024F1073-4C35-4EAC-BEFC-CF9B3462D668Q58788212-4695B112-459F-41D2-BE77-A5EB5B4B1B91
P2860
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Synthesis and characterization ...... nds for human β-adrenoceptors.
@en
type
label
Synthesis and characterization ...... nds for human β-adrenoceptors.
@en
prefLabel
Synthesis and characterization ...... nds for human β-adrenoceptors.
@en
P2093
P2860
P50
P356
P1476
Synthesis and characterization ...... ands for human β-adrenoceptors
@en
P2093
Karolina Salchow
Luke A Adams
Richard J Middleton
P2860
P304
P356
10.1021/JM2008562
P407
P577
2011-09-16T00:00:00Z